Recombinant multi-species SLC16A5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC16A5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the monocarboxylate transporter family and the major facilitator superfamily. The encoded protein is localized to the cell membrane and acts as a proton-linked transporter of bumetanide. Transport by the encoded protein is inhibited by four loop diuretics, nateglinide, thiazides, probenecid, and glibenclamide. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
The Alternative Names of target: A130015N09Rik,MCT 5,MCT 6,MCT5,MCT6,Monocarboxylate transporter 5 (MCT 5),Monocarboxylate transporter 6,SLC16A5,Slc16a5,Solute carrier family 16 member 5

Target products collectionGo to SLC16A5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1650-Ag-1/ GM-Tg-hg-IP1650-Ag-2 Human SLC16A5 protein Human
GM-Tg-rg-IP1650-Ag-1/ GM-Tg-rg-IP1650-Ag-2 Rat SLC16A5 protein Rat
GM-Tg-mg-IP1650-Ag-1/ GM-Tg-mg-IP1650-Ag-2 Mouse SLC16A5 protein Mouse
GM-Tg-cynog-IP1650-Ag-1/ GM-Tg-cynog-IP1650-Ag-2 Cynomolgus/Rhesus macaque SLC16A5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1650-Ag-1/ GM-Tg-felg-IP1650-Ag-2 Feline SLC16A5 protein Feline
GM-Tg-cang-IP1650-Ag-1/ GM-Tg-cang-IP1650-Ag-2 Canine SLC16A5 protein Canine
GM-Tg-bovg-IP1650-Ag-1/ GM-Tg-bovg-IP1650-Ag-2 Bovine SLC16A5 protein Bovine
GM-Tg-equg-IP1650-Ag-1/ GM-Tg-equg-IP1650-Ag-2 Equine SLC16A5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1650-Ag-1/ GM-Tg-hg-IP1650-Ag-2; GM-Tg-rg-IP1650-Ag-1/ GM-Tg-rg-IP1650-Ag-2;
GM-Tg-mg-IP1650-Ag-1/ GM-Tg-mg-IP1650-Ag-2; GM-Tg-cynog-IP1650-Ag-1/ GM-Tg-cynog-IP1650-Ag-2;
GM-Tg-felg-IP1650-Ag-1/ GM-Tg-felg-IP1650-Ag-2; GM-Tg-cang-IP1650-Ag-1/ GM-Tg-cang-IP1650-Ag-2;
GM-Tg-bovg-IP1650-Ag-1/ GM-Tg-bovg-IP1650-Ag-2; GM-Tg-equg-IP1650-Ag-1/ GM-Tg-equg-IP1650-Ag-2
Products Name SLC16A5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLC16A5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC16A5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.